Nevertheless, the presence of tumor infiltrating lymphocytes (TILs), which include T- NK- and other cells, has been associated with a favorable outcome in HER2-positive (and triple negative) BC patients [11-12], although, tumor cells develop a variety of mechanisms to avoid immune defense. The gene discussed is ERBB2; the disease is neoplasm.